By Kyle A. Diamantas JD – There may be no better illustration of the critical and integral role the U.S. Food and Drug Administration has played in the history of our nation’s health than the timely juxtaposition of two anniversaries occurring this year, our nation’s 250th and the FDA’s 120th.
HHS and the VA entered into a Memorandum of Understanding to strengthen collaboration on the research, clinical development, and responsible deployment to veterans suffering from serious mental health conditions of potential future rapid-acting psychedelic drug products if approved by the FDA.
HHS announced that Secretary Robert F. Kennedy, Jr. has signed determinations terminating the COVID-19 Emergency Use Authorization declarations for drugs and biological products and for medical devices, concluding that the circumstances that justified these emergency authorities no longer exist.
This final rule, Strengthening Oversight of AO and Preventing AO Conflicts of Interest, ensures that the organizations responsible for the oversight of more than 9,000 healthcare providers and suppliers use Medicare standards, and creates greater consistency between State Survey Agencies (SAs) and AOs in their respective survey processes.
The Administration for Strategic Preparedness and Response, a division of the U.S. Department of Health and Human Services, recently updated the Hospital Preparedness Program guidance for the third budget period of their cooperative agreement that covers Fiscal Year 2024 – Fiscal Year 2028.
Through this RFI, HHS is inviting stakeholders to provide feedback on how the Department can use its regulatory, reimbursement, and research & development levers across all of HHS to enable AI adoption to propel the American health care system forward.
The U.S. Department of Health and Human Services released its AI Strategy, the next phase of the Department’s transformative initiative to make artificial intelligence available to the federal workforce, integrating it across internal operations, research, and public health.
The Health Resources and Services Administration released new data showing HRSA-funded health centers served over 32.4 million patients in 2024 — the most patients ever served in the Health Center Program’s 60-year history.
On July 31, 2025, the Centers for Medicare & Medicaid Services issued a final rule for updates to Medicare payment policies and rates for skilled nursing facilities under the Skilled Nursing Facility Prospective Payment System for fiscal year 2026.
The CMS Making Health Tech Great Again initiative is announced. “Let’s stop waiting and let’s definitely stop faxing. Let’s start building. The right data at the right time can mean the difference between loss and hope. The time is now. Are you in?”
CMS 2026 Physician Fee Schedule Proposed Rule. The 60-day comment period for the CY 2026 PFS proposed rule (CMS-1832 P) ends on September 12, 2025.
This program is designed to support communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment, cure infections, and reduce reinfection by Hepatitis C (a liver disease caused by the Hepatitis C virus).
©2026 Answers Media Company, LLC